All the above disorders and their associations with abnormality of NK and CD8+ T cells encourage further investigation of different lymphocytes, particularly the deficiency or over-activity of NK and CD8+ T cells, in designing therapeutic protocols for not only dealing with pathogens and cancers but also many disorders associated with immunodysregulation. This evidence concerns the gene CD8A and cancer.